Latest News

How Covid-19 is accelerating adoption of decentralized clinical trials

Late last month, Medable and LabCorp CRO Covance signed a deal to accelerate adoption of decentralized trials, a trend that has been helped along as Covid-19 has created challenges to conducting trials dependent on traditional brick-and-mortar sites.

Source link

Related posts

Near-lockdown in the Bay Area ‘ratchets up’ challenges for local biotechs and labs


App assists doctors, patients navigating domestic abuse


LCGC® Presents ‘Advances in Gas Chromatography for DHA, PONA and PIANO Analysis, in Fuels by Single and Multidimensional GC Techniques’ Webcast


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World